X

Download Multiple myeloma definition PowerPoint Presentation


Login   OR  Register
X

Share page



  Preview

               
Home / Health & Wellness / Health & Wellness Presentations / Multiple myeloma definition PowerPoint Presentation

Multiple myeloma definition PowerPoint Presentation

onlinesearch By : onlinesearch

On : Feb 24, 2014

In : Health & Wellness

Embed :
494
views

0
downloads
Login / Signup - with account for


  • → Make favorite
  • → Flag as inappropriate
  • → Download Presentation
  • → Share Presentation
  • Slide 1 - Multiple Myeloma Definition: B-cell malignancy characterised by abnormal proliferation of plasma cells able to produce a monoclonal immunoglobulin (M protein) Incidence: 3 - 9 cases per 100000 population / year more frequent in elderly modest male predominance
  • Slide 2 - Multiple myeloma
  • Slide 3 - Multiple Myeloma Clinical forms: multiple myeloma solitary plasmacytoma plasma cell leukemia M protein: - is seen in 99% of cases in serum and/or urine IgG > 50%, IgA 20-25%, IgE i IgD 1-3% light chain 20% - 1% of cases are nonsecretory
  • Slide 4 - Multiple Myeloma Clinical manifestations are related to malignant behavior of plasma cells and abnormalities produced by M protein plasma cell proliferation: multiple osteolytic bone lesions hypercalcemia bone marrow suppression ( pancytopenia ) monoclonal M protein decreased level of normal immunoglobulins hyperviscosity
  • Slide 5 - Multiple Myeloma
  • Slide 6 - Multiple Myeloma Clinical symptoms: bone pains, pathologic fractures weakness and fatigue serious infection renal failure bleeding diathesis
  • Slide 7 - Multiple Myeloma Laboratory tests: ESR > 100 anaemia, thrombocytopenia rouleaux in peripheral blood smears marrow plasmacytosis > 10 -15% hyperproteinemia hypercalcemia proteinuria azotemia
  • Slide 8 - Diagnostic Criteria for Multiple Myeloma Major criteria I. Plasmacytoma on tissue biopsy II. Bone marrow plasma cell > 30% III. Monoclonal M spike on electrophoresis IgG > 3,5g/dl, IgA > 2g/dl, light chain > 1g/dl in 24h urine sample Minor criteria a. Bone marrow plasma cells 10-30% b. M spike but less than above c. Lytic bone lesions d. Normal IgM < 50mg, IgA < 100mg, IgG < 600mg/dl
  • Slide 9 - Multiple Myeloma
  • Slide 10 - Diagnostic Criteria for Multiple Myeloma Diagnosis: I + b, I + c, I + d II + b, II + c, II + d III + a, III + c, I II + d a + b + c, a +b + d
  • Slide 11 - Staging of Multiple Myeloma Clinical staging (Salmon-Durie) is based on level of haemoglobin, serum calcium, immunoglobulins and presence or not of lytic bone lesions correlates with myeloma burden and prognosis I. Low tumor mass II. Intermediate tumor mass III. High tumor mass subclassification A - creatinine < 2mg/dl B - creatinine > 2mg/dl
  • Slide 12 - Multiple myeloma MGUS – monoclonal gammapathy of undetermined significance Smoldering multiple myeloma Symptomatic multiple myeloma
  • Slide 13 - Monoclonal gammopathy of undetermined significance ( MGUS) M protein present, stable levels of M protein: IgG < 3,0g IgA < 2g LC<1g/day normal immunoglobulins - normal levels marrow plasmacytosis < 10% complete blood count - normal no lytic bone lesions no signs of disease
  • Slide 14 - Smoldering multiple myeloma M protein present, stable levels of M protein: IgG  3,0g IgA  2g LC  1g/day normal immunoglobulins - normal levels marrow plasmacytosis  10% complete blood count - normal no lytic bone lesions no signs of disease
  • Slide 15 - Diagnostic Criteria for Multiple Myeloma Plasma cell ≥ 10% in the bone marrow or tissue biopsy Monoclonal protein  3g/dl in the serum or urine (>1g/dl) Presence of end-organ damage Hypercalcemia Ca > 2,75 mmol/l Renal insufficiency Creatinine > 173 mmol/l Anemia Hb < 10g/dl Bone lesions Lytic lesions or osteopenia with compression fractures Other Symptomatic hyperviscosity, amyloidosis, recurrent bacterial infection (> 2 episodes in 12 months)
  • Slide 16 - Multiple Myeloma Poor prognosis factors beta-2 microglobulin > 3,5 mg/l albumin > 3,5 g/dl cytogenetical abnormalities: 13q del; t(4,14)
  • Slide 17 - Treatment of Multiple Myeloma Conventional chemotherapy High dose therapy and autologous hematopoietic stem cell transplantation Reduced intensity conditioning with allogeneic stem cell transplantation
  • Slide 18 - Treatment of Multiple Myeloma Patients < 65 - 70 years high-dose therapy with autologous stem cell transplantation allogeneic stem cell transplantation (conventional and „mini”) Patients > 65 - 70 years conventional chemotherapy
  • Slide 19 - Treatment of Multiple Myeloma Conventional Treatment Talidomide + Dexamethasone VAD (Vincristin, Adriamycin, Dexamethasone) Melphlan + Prednisone M2 (Vincristine, Melphalan, Cyclophosphamid, BCNU, Prednisone) D (Dexamethasone) Response rate 50-60% patients Long term survival 5-10% patients
  • Slide 20 - Treatment of Multiple Myeloma Autologous transplantation (tandem) patients < 65-70 years treatment related mortality < 5 -10% response rate 80% long term survival 20-40% Conventional allogeneic transplantation patients < 45-50 years with HLA-identical donor treatment related mortality 40-50% long term survival 20-30%
  • Slide 21 - Treatment of Multiple Myeloma Event-free and overall survival times of 515 patients receiving autotransplants and a median follow-up of at least 5 years.
  • Slide 22 - Treatment of Multiple Myeloma Novel method Non-myeloablative therapy and allogeneic transplantation Tandem transplants Bortesomib (proteasome inhibitor) Lenalidomid Arsenic trioxide Statins
  • Slide 23 - Treatment of Multiple Myeloma Supportive treatment biphosphonates, calcitonin recombinant erythropoietin immunoglobulins plasma exchange radiation therapy
  • Slide 24 - Disorder Associated with Monoclonal Protein Neoplastic cell proliferation multiple myeloma solitary plasmacytoma Waldenstrom macroglobulinemia heavy chain disease primary amyloidosis Undetermined significance monoclonal gammopathy of undetermined significance (MGUS) Transient M protein viral infection post-valve replacement Malignacy bowel cancer, breast cancer Immune dysregulation AIDS, old age Chronic inflamation
  • Slide 25 - Monoclonal gammopathy of undetermined significance ( MGUS) M protein 3% of people > 70 years 15% of people > 90 years MGUS is diagnosed in 67% of patients with an M protein 10% of patients with MGUS develop multiple myeloma

Description : Available Multiple myeloma definition powerpoint presentation for free download which is uploaded by search an active user in belonging ppt presentation Health & Wellness category.

Tags : Multiple myeloma definition

Shortcode : Get Shareable link